Diagnostic and prognostic values of serum exosomal microRNA-21 in children with hepatoblastoma: a Chinese population-based study

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Pediatric surgery international (Print)

• Publication date

  2016-09-06

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00383-016-3960-8PMID 27601233
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• MicroRNA-21 promotes phosphatase gene and protein kinase B/phosphatidylinositol 3-kinase expression in colorectal cancer.

  2016cited by this paper
• Multi-platform microRNA profiling of hepatoblastoma patients using formalin fixed paraffin embedded archival samples

  2015cited by this paper
• Exosomes in cancer: small particle, big player

  2015cited by this paper
• MiRNA-based therapeutic intervention of cancer

  2015cited by this paper
• Circulating miR-199a-3p as a novel serum biomarker for colorectal cancer.

  2014cited by this paper
• Predictors of survival after resection of children with hepatoblastoma: A single Asian center experience.

  2014cited by this paper
• miR-133a functions as a tumor suppressor and directly targets FSCN1 in pancreatic cancer.

  2014cited by this paper
• microRNA expression might predict prognosis of epithelial hepatoblastoma

  2014cited by this paper
• microRNAs in the tumor microenvironment: solving the riddle for a better diagnostics

  2014cited by this paper
• The Majority of MicroRNAs Detectable in Serum and Saliva Is Concentrated in Exosomes

  2012cited by this paper
• Circulating microRNA-21 as a novel biomarker for hepatocellular carcinoma.

  2012cited by this paper
• Tumor cell-derived exosomes: a message in a bottle.

  2012cited by this paper
• Prognostic stratification for children with hepatoblastoma: the SIOPEL experience.

  2012influential reference
• Exosomes: current knowledge of their composition, biological functions, and diagnostic and therapeutic potentials.

  2012cited by this paper
• A multiplex quantitative proteomics strategy for protein biomarker studies in urinary exosomes.

  2012cited by this paper
• Expression and function of miRNA in postoperative radiotherapy sensitive and resistant patients of non-small cell lung cancer.

  2011cited by this paper
• Stem cell-like micro-RNA signature driven by Myc in aggressive liver cancer

  2010cited by this paper
• Predictive power of pretreatment prognostic factors in children with hepatoblastoma: A report from the Children's Oncology Group

  2009cited by this paper
• Survival trends in children with hepatoblastoma

  2009cited by this paper
• Hepatic stem-like phenotype and interplay of Wnt/beta-catenin and Myc signaling in aggressive childhood liver cancer.

  2008cited by this paper
• Hepatoblastoma with a low serum alpha-fetoprotein level at diagnosis: the SIOPEL group experience.

  2008cited by this paper
• Surgical treatment of hepatoblastoma in children

  2006cited by this paper
• The current management of hepatoblastoma: a combination of chemotherapy, conventional resection, and liver transplantation.

  2005cited by this paper
• Exosomal-like vesicles are present in human blood plasma.

  2005cited by this paper
• Liver transplantation for hepatoblastoma: Results from the International Society of Pediatric Oncology (SIOP) study SIOPEL‐1 and review of the world experience

  2004cited by this paper
• Pretreatment prognostic factors and treatment results in children with hepatoblastoma

  2002cited by this paper
• Surgical view of the treatment of patients with hepatoblastoma

  2002cited by this paper
• Efficiency and toxicity of ifosfamide, cisplatin and doxorubicin in the treatment of childhood hepatoblastoma. Study Committee of the Cooperative Paediatric Liver Tumour Study HB89 of the German Society for Paediatric Oncology and Haematology.

  1997cited by this paper
• Prognostic factors and staging systems in childhood hepatoblastoma

  1997cited by this paper
• Receiver operating characteristic (ROC) methodology: the state of the art.

  1989cited by this paper
• Regression Models and Life-Tables

  1972cited by this paper
• Regression Models and Life-Tables

  year unknowncited by this paper

• Insights into the mechanisms of microRNAs in hepatoblastoma: from diagnosis to treatment

  2025cites this paper
• Identification of MAD2L1 as a novel biomarker for hepatoblastoma through bioinformatics and machine learning approaches

  2025cites this paper
• Exosomal CCT3 as a biomarker for diagnosis and immune therapy response in patients diagnosed with hepatocellular carcinoma.

  2025cites this paper
• A comprehensive overview of liquid biopsy applications in pediatric solid tumors

  2024cites this paper
• Exosomes: Key Players for Treatment of Cancer and Their Future Perspectives

  2024cites this paper
• Extracellular Vesicles for Childhood Cancer Liquid Biopsy

  2024cites this paper
• Unlocking the Secrets of Extracellular Vesicles: Orchestrating Tumor Microenvironment Dynamics in Metastasis, Drug Resistance, and Immune Evasion

  2024cites this paper
• Role of exosomes in diagnosis, prognostication, and treatment of pediatric solid tumors

  2024cites this paper
• Exosomal microRNAs in cancer: Potential biomarkers and immunotherapeutic targets for immune checkpoint molecules

  2023cites this paper
• Ferroptosis regulator NOS2 is closely associated with the prognosis and cell malignant behaviors of hepatoblastoma: a bioinformatic and in vitro study

  2023cites this paper
• Circulating exosomal microRNAs as potential prognostic biomarkers in gastrointestinal cancers: a systematic review and meta-analysis

  2023cites this paper
• The Role of miRNAs, circRNAs and Their Interactions in Development and Progression of Hepatocellular Carcinoma: An Insilico Approach

  2022cites this paper
• MicroRNAs as early diagnostic biomarkers for non‑small cell lung cancer (Review).

  2022cites this paper
• Exosomes and cancer - Diagnostic and prognostic biomarkers and therapeutic vehicle

  2022cites this paper
• Extracellular Vesicles: A New Source of Biomarkers in Pediatric Solid Tumors? A Systematic Review

  2022cites this paper
• Hepatoblastoma: Derived Exosomal LncRNA NEAT1 Induces BMSCs Differentiation into Tumor-Supporting Myofibroblasts via Modulating the miR-132/MMP9 Axis

  2022cites this paper
• Noncoding RNAs in liver cancer patients

  2022cites this paper
• Exosomes as potential diagnosis and treatment for liver cancer

  2022cites this paper
• Identification of Ten Core Hub Genes as Potential Biomarkers and Treatment Target for Hepatoblastoma

  2021cites this paper
• Diagnostic and Prognostic Value of miRNAs in Hepatoblastoma: A Systematic Review With Meta-Analysis

  2021cites this paper
• Integrative Analysis of DNA Methylation and Gene Expression Profiling Data Reveals Candidate Methylation-Regulated Genes in Hepatoblastoma

  2021cites this paper
• Exosome-Derived microRNA: Efficacy in Cancer

  2021cites this paper
• Exosomal miR-214-3p as a potential novel biomarker for rhabdoid tumor of the kidney

  2021cites this paper
• The Role of Extracellular Vesicles as Shuttles of RNA and Their Clinical Significance as Biomarkers in Hepatocellular Carcinoma

  2021cites this paper
• Isolation and characterization of extracellular vesicles for clinical applications in cancer – time for standardization?

  2021cites this paper
• The miR-21 potential of serving as a biomarker for liver diseases in clinical practice.

  2020cites this paper
• Cross talk between RNA N6‐methyladenosine methyltransferase‐like 3 and miR‐186 regulates hepatoblastoma progression through Wnt/β‐catenin signalling pathway

  2020cites this paper
• Liver-derived extracellular vesicles: A cell by cell overview to isolation and characterization practices.

  2020cites this paper
• MicroRNA and liver cancer

  2020cites this paper
• MicroRNAs: potential biomarkers for diagnosis and prognosis of different cancers

  2020cites this paper
• Cancer-Derived Exosomes: Their Role in Cancer Biology and Biomarker Development

  2020cites this paper
• Clinical significance of exosomes as potential biomarkers in cancer

  2019cites this paper
• MicroRNA-17, MicroRNA-19b, MicroRNA-146a, MicroRNA-302d Expressions in Hepatoblastoma and Clinical Importance

  2019cites this paper
• Progress toward liquid biopsies in pediatric solid tumors

  2019cites this paper
• The Long Non-coding RNA ZFAS1 Sponges miR-193a-3p to Modulate Hepatoblastoma Growth by Targeting RALY via HGF/c-Met Pathway

  2019cites this paper
• Circulating exosomal miRNAs: clinical significance in human cancers

  2019cites this paper
• Effect of miR-21 on apoptosis in hepatoblastoma cell through activating ASPP2/p38 signaling pathway in vitro and in vivo

  2019cites this paper
• DPEP1 is a direct target of miR-193a-5p and promotes hepatoblastoma progression by PI3K/Akt/mTOR pathway

  2019cites this paper
• Exosomal MiRNAs in Pediatric Cancers

  2019cites this paper
• A meta-analysis on the prognosis of exosomal miRNAs in all solid tumor patients

  2019influential citation
• MicroRNA dysregulation interplay with childhood abdominal tumors

  2019cites this paper
• The Role of MicroRNAs in Hepatoblastoma Tumors

  2019cites this paper
• The Relationship between Exosomes and Cancer: Implications for Diagnostics and Therapeutics

  2019cites this paper
• The utility of serum exosomal microRNAs in hepatocellular carcinoma.

  2019cites this paper
• Extracellular Vesicles in Hepatobiliary Malignancies

  2018cites this paper
• MicroRNA expression patterns and signalling pathways in the development and progression of childhood solid tumours

  2017cites this paper
• Diagnostic and therapeutic applications of tumor‐associated exosomes

  2017cites this paper
• Functional Roles and Therapeutic Applications of Exosomes in Hepatocellular Carcinoma

  2017cites this paper
• Extracellular vesicles: Novel mediator for cell to cell communications in liver pathogenesis.

  2017cites this paper
• Exosomal miRNAs as biomarkers in the diagnosis of liver disease.

  2017cites this paper
• RNA-seq reveals distinctive RNA profiles of small extracellular vesicles from different human liver cancer cell lines

  2017cites this paper